NLS-2

N/A

Report date: 2022/12/17 17:10:11
NME

Base Information

Drug NameNLS-2
Drug Alias NameNLS-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonistsMonoamine reuptake inhibitor
TargetsOrexin receptor type 2Monoamine transporters
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityRestless Legs Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNls Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNls Pharma
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityRestless Legs Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A